Results 71 to 80 of about 18,691 (198)

If treating obesity with GLP‐1‐based therapies protects the heart, could it also prevent cancer or improve cancer outcomes? The case for randomized trials

Diabetes, Obesity and Metabolism, EarlyView.
Anastasios Tentolouris, Ioannis Ntanasis‐Stathopoulos   +1 more
wiley   +1 more source

Metaplastic carcinoma of the breast: A diagnostic dilemma

Saudi Journal of Medicine and Medical Sciences, 2015
Metaplastic carcinomas of the breast are malignant neoplasms composed of a mixture of epithelial and mesenchymal elements. They are rare with incidence of lesser than 1% of invasive breast carcinoma.
Vani B Ramalingiah, Geethamala Kempula, Panduranga Chikkannaiah, Srinivasamurthy Venkataramappa   +3 more
doaj   +1 more source

Partial Response After Toripalimab Plus Anlotinib for Advanced Metaplastic Breast Carcinoma: A Case Report [PDF]

, 2022
Yang Fu, Jie Liu, Yu Jiang
openalex   +1 more source

CV‐SCAN (Crystal Violet Staining for Colitis‐Associated Neoplasia): A Novel Endoscopic Staining Method to Detect Paneth Cell Metaplasia and Ulcerative Colitis (UC)‐Associated Neoplasia in UC

Digestive Endoscopy, Volume 38, Issue 1, January 2026.
ABSTRACT Objectives Paneth cell metaplasia (PCM), a metaplastic change associated with chronic inflammation in ulcerative colitis (UC), may be linked to UC‐associated neoplasia (UCAN). However, no endoscopic method currently exists for detecting PCM. This study aimed to develop and validate a novel endoscopic staining technique—CV‐SCAN—for identifying ...
Akira Tomioka, Nanoka Chiya, Chie Kurihara, Yoshikiyo Okada, Kazuyuki Narimatsu, Masaaki Higashiyama, Shunsuke Komoto, Ryota Hokari   +7 more
wiley   +1 more source

Treatment‐related changes in the prostate: past, present and future therapies

Histopathology, Volume 88, Issue 1, Page 40-52, January 2026.
Radiation therapy alters tumour morphology and immunoprofile in prostate cancer. Residual carcinoma shows distorted glandular architecture on H&E and loss of basal markers with preserved AMACR expression by immunohistochemistry, aiding in the recognition of treatment effect in prostate biopsies.
Katrina Collins, Liang Cheng
wiley   +1 more source

Immunohistochemical characterization of peritoneal inclusion cysts with squamous metaplasia

Histopathology, Volume 88, Issue 2, Page 533-537, January 2026.
Aims Peritoneal inclusion cysts (PICs) are mesothelial‐lined cysts that can uncommonly develop squamous metaplasia. Here, we describe the immunophenotype of PICs with squamous metaplasia using a comprehensive immunohistochemical (IHC) panel. Methods and results We collected surgical excisions of PICs with squamous metaplasia from our institution and ...
Heather I Chen‐Yost, David B Chapel, Steven M Hrycaj, William R Perry, Kristine E Konopka, Jeffrey L Myers, Tao Huang   +6 more
wiley   +1 more source

Clinicopathological Profile of Intraosseous Adenoid Cystic Carcinoma of the Jaws: A Systematic Review

Journal of Oral Pathology &Medicine, Volume 55, Issue 1, Page 32-41, January 2026.
ABSTRACT Objectives We aimed to evaluate the clinicopathological features, survival rate, and potential prognostic markers of the jaws' primary intraosseous adenoid cystic carcinoma (PIACC). Materials and Methods MEDLINE/PubMed, Scopus, and Embase searches were performed with the keywords “adenoid cystic carcinoma,” and “jaw,” or “maxilla,” or ...
Luccas Lavareze, João Figueira Scarini, Reydson Alcides de Lima‐Souza, Talita de Carvalho Kimura, Rogério de Oliveira Gondak, Erika Said Abu Egal, Albina Altemani, Fernanda Viviane Mariano   +7 more
wiley   +1 more source

A Phase II Pilot Study of Anti‐PD‐L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple‐Negative Breast Cancer With or Without Germline BRCA Mutation

Cancer Medicine, Volume 14, Issue 23, December 2025.
ABSTRACT Background Immunostimulatory effects of PARP inhibitors could increase sensitivity to immune checkpoint inhibitors. The previous Phase II trial (MEDIOLA) reported clinical benefits of durvalumab and olaparib (D + O) in patients with germline BRCA‐mutated (gBRCAm) HER2‐negative metastatic breast cancer.
Takeo Fujii, Ashley Cimino‐Mathews, Stanley Lipkowitz, Min‐Jung Lee, Jayakumar Nair, Britanny Brooke Solarz, Alexandra Zimmer, Bernadette Redd, Elliot B. Levy, Shraddha Rastogi, Nahoko Sato, Ann McCoy, Seth M. Steinberg, Jung‐Min Lee   +13 more
wiley   +1 more source

Supplementary Figure S3 from The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas

, 2023
Charlotte K.Y. Ng, Salvatore Piscuoglio, Felipe C. Geyer, Kathleen A. Burke, Fresia Pareja, Carey A. Eberle, Raymond S. Lim, Rachael Natrajan, Nadeem Riaz, Odette Mariani, Larry Norton, Anne Vincent‐Salomon, Y. Hannah Wen, Britta Weigelt, Jorge S. Reis‐Filho   +14 more
openalex   +2 more sources

Fibromatosis-like carcinoma-an unusual phenotype of a metaplastic breast tumor associated with a micropapilloma

World Journal of Surgical Oncology, 2007
Background Fibromatosis-like metaplastic carcinoma is a newly described metaplastic breast tumor, literature on which is still evolving. Case presentation A 77-year-old lady presented with a 2 × 2 cm mass with irregular margins in the upper and outer ...
Badwe Rajan A, Shet Tanuja M, Rekhi Bharat, Chinoy Roshni F   +3 more
doaj   +1 more source